/**/
RNS Number : 9945F
JPMorgan Securities Plc
17 November 2015
 
Ap24

 

FORM 38.5(a)

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 38.5(a) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

 

DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITH RECOGNISED INTERMEDIARY STATUS AND DEALING IN A CLIENT-SERVING CAPACITY

 

1.       KEY INFORMATION

 

Name of exempt principal trader

J.P. Morgan Securities plc

Company dealt in

Pfizer Inc

Class of relevant security to which the dealings being disclosed relate (Note 1)

Common Stock

Date of dealing

16 November 2015

 

2.        DEALINGS (Note 2)

 

(a)      Purchases and sales

 

Total number of relevant secuities acquired

Highest price paid (EUR)
(Note 3)

Lowest price paid (EUR)

(Note 3)

59

30.7550

30.7550

 

 

Total number of securities disposed

Highest price received  (USD) (Note 3)

Lowest price received (USD)

(Note 3)




 

(b)      Derivatives transactions (other than options transactions)

 

Product name,

e.g. CFD

Nature of transaction

(Note 4)

Number of relevant securities

(Note 5)

Price per unit (EUR)

(Note 3)

Equity Swap

Short

59

30.7579


Ap25

 

(c)      Options transactions in respect of existing relevant securities

 

 

(i)       Writing, selling, purchasing or varying

 

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 5)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 3)








 

 

(ii)      Exercising

 

Product name,

e.g. call option

Number of securities

Exercise price per unit (Note 3)




 

 

3.      OTHER INFORMATION

 

Agreements, arrangements or understandings relating to options or derivatives

 

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities
 under any option referred to on this form or relating to the voting rights or future acquisition 
or disposal of any relevant securities to which any derivative referred to on this form is referenced. 
If none, this should be stated.

 

 

 

 

 

 

Date of disclosure

17 November 2015

Contact name

Tung Le

 

Telephone number

020 7742 7272

Name of offeree/offeror with which connected

Allergan Plc

Nature of connection (Note 6)

Adviser to Allergan Plc

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ISEUBAARVSAAAAA
Pfizer (LSE:PFZ)
Gráfico Histórico do Ativo
De Jan 2025 até Fev 2025 Click aqui para mais gráficos Pfizer.
Pfizer (LSE:PFZ)
Gráfico Histórico do Ativo
De Fev 2024 até Fev 2025 Click aqui para mais gráficos Pfizer.